These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol. Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK; Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987 [TBL] [Abstract][Full Text] [Related]
11. Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Patel B; Kirkwood AA; Dey A; Marks DI; McMillan AK; Menne TF; Micklewright L; Patrick P; Purnell S; Rowntree CJ; Smith P; Fielding AK Leukemia; 2017 Jan; 31(1):58-64. PubMed ID: 27480385 [TBL] [Abstract][Full Text] [Related]
12. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study. Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155 [TBL] [Abstract][Full Text] [Related]
13. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome. Hanbali A; Kotb A; El Fakih R; Alfraih F; Ahmed SO; Shaheen M; Hashmi S; Alhayli S; Alahmari A; Riash MA; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):670-677. PubMed ID: 31377206 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia. Douer D; Aldoss I; Lunning MA; Burke PW; Ramezani L; Mark L; Vrona J; Park JH; Tallman MS; Avramis VI; Pullarkat V; Mohrbacher AM J Clin Oncol; 2014 Mar; 32(9):905-11. PubMed ID: 24516026 [TBL] [Abstract][Full Text] [Related]
15. Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature. Blackman A; Boutin A; Shimanovsky A; Baker WJ; Forcello N J Oncol Pharm Pract; 2018 Jul; 24(5):393-397. PubMed ID: 28523950 [TBL] [Abstract][Full Text] [Related]
17. Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report. Gallant R; Bonney P; Peek L; Yu Z; Crawford D Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27748018 [No Abstract] [Full Text] [Related]
18. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia]. Cooperation Group of Phase II Clinical Trial of PEG-Asp Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):29-33. PubMed ID: 18512312 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia]. Liu F; Wan Y; Chang L; Guo Y; Yang W; Wang S; Chen X; Liu T; Ruan M; Zhang L; Liu X; Zou Y; Chen Y; Zhu X Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):215-7. PubMed ID: 24824393 [TBL] [Abstract][Full Text] [Related]
20. Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review. Hasan H; Shaikh OM; Rassekh SR; Howard AF; Goddard K Pediatr Blood Cancer; 2017 Jan; 64(1):81-88. PubMed ID: 27578304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]